Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPLORE: Vaginal Estrogen Therapy and Microbiomes in Postmenopausal Women
NCT03996603Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Aug 2019
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Estrogen vaginal cream in Vulvovaginal atrophy (VVA) (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: Quantitative Change in Relative Abundance of Lactobacillus Among the Community Composition of Bacteria in the Vagina at 8 weeks. Started Aug 2019; status: completed.
02
Drugs
Estrogen vaginal cream
03
Conditions
Vulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT03996603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03996603.